• 1
    Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12: 151180.
  • 2
    Reiter RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998; 56: 359384.
  • 3
    Reiter RJ, Tan DX, Burkhardt S. Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin. Mech Aging Develop 2002; 123: 10071019.
  • 4
    Albarrán MT, López-Burillo S, Pablos MI et al. Endogenous rhythms of melatonin, total antioxidant status and superoxide dismutase activity in several tissues of chick and their inhibition by light. J Pineal Res 2001; 30: 227233.
  • 5
    Okatani Y, Wakatsuki A, Shinohara K et al. Melatonin stimulates glutathione peroxidase activity in human chorion. J Pineal Res 2001; 30: 199205.
  • 6
    Antunes F, Ross L, Barclay C et al. On the antioxidant activity of melatonin. Free Radic Biol Med 1999; 26: 117128.
  • 7
    Reiter RJ, Tan DX, Qi W et al. Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biol Sig Recept 2000; 9: 160171.
  • 8
    Pappolla MA, Sos M, Omar RA et al. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J Neurosci 1997; 17: 16831690.
  • 9
    Pappolla MA, Poeggeler B, Reiter RJ. La hipótesis oxidativa en la enfermedad de Alzheimer. Papel de la melatonina como antioxidante y como agente antibeta amiloide. Antioxidantes y Calidad de Vida 2001; 8: 819.
  • 10
    Shen YX, Xu SY, Wei W et al. Melatonin blocks rat hippocampal neuronal apoptosis induced by amyloid beta-peptide 25–35. J Pineal Res 2002; 32: 163167.
  • 11
    Acuña-Castroviiejo D, Coto-Montes A, Monti MG et al. Melatonin is protective against MPTP-induced striatal and hipocampal lesions. Life Sci 1997; 60: PL23PL29.
  • 12
    Shen YX, Xu SY, Wei W et al. Melatonin reduces memory changes and neural oxidative damage in mice treated with d-galactose. J Pineal Res 2002; 32: 173178.
  • 13
    Tan DX, Manchester LC, Reiter RJ et al. A novel melatonin metabolite, cyclic 3-hydroxy-melatonin: a biomarker of in vivo hydroxyl radical generation. Biochem Biophys Res Commun 1998; 253: 614620.
  • 14
    Cabrera J, Reiter RJ, Tan DX et al. Melatonin reduces oxidative neurotoxicity due to quinolinic acid: in vitro and in vivo findings. Neuropharmacology 2000; 39: 507514.
  • 15
    Khaldy H, Escames G, León J et al. Comparative effects of melatonin, l-deprenyl, Trolox and ascorbate in the suppression of hydroxyl radical formation during dopamine autoxidation in vitro. J Pineal Res 2000; 29: 100107.
  • 16
    Reiter RJ, Tan DX, Karbownik M. Cholelithiasis, oxidative stress and melatonin. J Pineal Res 2001; 30: 127128.
  • 17
    Hsu CH, Chi BC, Casida JE. Melatonin reduces phosphine-induced lipid and DNA oxidation in vitro and in vivo in rat brain. J Pineal Res 2002; 32: 5358.
  • 18
    Tian YM, Li PP, Jiang XF et al. Rejuvenation of degenerative thymus by oral melatonin administration and the antagonistic action of melatonin against hydroxyl radical-induced apoptosis of cultured thymocytes in mice. J Pineal Res 2001; 31: 214221.
  • 19
    Tesoriere L, D'Arpa D, Conti S et al.. Melatonin protects human red blood cells from oxidative hemolyses: new insights into the radical-scavenging activity. J Pineal Res 1999; 27: 95105.
  • 20
    Melchiorri D, Ortiz GG, Reiter RJ et al. Melatonin reduces paraquat-induced genotoxicity in mice. Toxicol Lett 1998; 95: 103108.
  • 21
    Fulia F, Gitto E, Cuzzzocrea S et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 2001; 31: 343349.
  • 22
    Acunã-Castroviejo D, MatÍn M, MacÍas M et al. Melatonin, mitochondria, and cellular bioenergetics. J Pineal Res 2001; 30: 6574.
  • 23
    Tan DX, Manchester LC, Hardeland R et al. Melatonin: a hormone, a tissue factor, an autacoid, a paracoid and an antioxidant vitamin. J Pineal Res 2003; 34: 7578.
  • 24
    Kehrer JP. Free radicals as mediator of tissue injury and disease. Crit Rev Toxicol 1993; 23: 2148.
  • 25
    Wink DA, Mitchell JB. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 1998; 25: 434456.
  • 26
    Radi R, Peluffo G, Alvarez MN et al. Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 2001; 30: 463488.
  • 27
    Pozo D, Reiter RJ, Calvo JR et al. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J Cell Biochem 1997; 65: 430442.
  • 28
    Escames G, Guerrero JM, Reiter RJ et al. Melatonin and vitamin E limit nitric oxide-induced lipid peroxidation in rat brain homogenates. Neurosci Lett 1997; 230: 147150.
  • 29
    Okatani Y, Wakatsuki A, Watanabe K et al. Weak vasoconstrictor activity of melatonin in human umbilical artery: relation to nitric oxide-scavenging action. Eur J Pharmacol 2001; 417: 125129.
  • 30
    Siu AW, Reiter RJ, To CH. Pineal indoleamines and vitamin E reduce nitric oxide-induced lipid peroxidation in rat retinal homogenates. J Pineal Res 1999; 27: 122128.
  • 31
    Wakatsuki A, Okatani Y. Melatonin protects against the free radical-induced impairment of nitric oxide production in the human umbilical artery. J Pineal Res 2000; 28: 172178.
  • 32
    Chang HM, Ling EA, Lue JH et al. Melatonin attenuates neuronal NADPH-d/NOS expression in the hypoglossal nucleus of adult rats following peripheral nerve injury. Brain Res 2002; 873: 243251.
  • 33
    Halliwell B, Gutteridge JMC. Free Radical in Biology and Medicine, 3 edn. Oxford University Press, Oxford, 2000.
  • 34
    Vivot E, Munoz JD, Cruanes MC et al. Inhibitory activity of xanthine-oxidase and superoxide scavenger properties of Inga verna subsp. affinis. Its morphological and micrographic characteristics. J Ethnopharmacol 2001; 76: 6571.
  • 35
    Schenkman JB, Cint DL. Preparation of microsomes with calcium. Meth Enzymol 1978; 52: 8389.
  • 36
    Lowry OH, Rosebrough NJ, Farr AL et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265275.
  • 37
    Creczynski-Pasa TB, Gräber P. ADP binding and ATP synthesis by reconstituted H+-ATPase from chloroplasts. FEBS Lett 1994; 350: 195198.
  • 38
    Bird RP, Draper AH. Comparative studies on different methods of malondyaldehyde determination. Meth Enzymol 1984; 90: 105110.
  • 39
    Gutteridge JMC, Halliwell B. The deoxyribose assay: an assay for ‘‘free’’ hydroxyl radical and for site-specific hydroxyl radical production. Biochem J 1988; 253: 931933.
  • 40
    Kopenol WH, Kissner R, Beckman JS. Synthesis of peroxynitrite: to go with the flow or solid grounds? Meth Enzymol 1996; 269: 296302.
  • 41
    Gross SS. Microtiter plate assay for determining kinetics of nitric oxide synthesis. Meth Enzymol 1996; 268: 159168.
  • 42
    Green LC, Wagner DA, Glogowiski J et al. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131138.
  • 43
    Robak J, Gryglewski RJ. Flavonoids are scavengers of superoxide radical. Biochem Pharmacol 1988; 5: 837841.
  • 44
    Rao TS, Yu SS, Djuric SW et al. Phorbol ester-induced dermal inflammation in mice: evaluation of inhibitors of 5-lipoxygenase and antagonists of leukotriene B4 receptor. J Lipid Mediat Cell Signal 1994; 10: 213228.
  • 45
    Simic MG, Jovanovic SV. Anti-oxidation mechanisms of uric acid. J Am Chem Soc 1989; 111: 57785781.
  • 46
    Blanchard B, Pompon D, Ducrocq C. Nitrosation of melatonin by nitric oxide and peroxynitrite. J Pineal Res 2000; 29: 184192.
  • 47
    Noda Y, Mori A, Liburdy R et al. Melatonin and its precursors scavenge nitric oxide. J Pineal Res 1999; 39: 101193.
  • 48
    Kettle AJ, Winterbourn CC. A kinetic analysis of the catalase activity of myeloperoxidase. Biochemistry 2001; 40: 10,20410,212.
  • 49
    Marquez LA, Dunford HB. Kinetics of oxidation of tyrosine and dityrosine by myeloperoxidase compounds I and II. J Biol Chem 1996; 270: 30,43430,440.
  • 50
    Antolin I, Rodriguez C, Sainz RM et al. Melatonin prevents cell damage effect on gene expression for antioxidant enzymes. FASEB J 1996; 10: 882890.
  • 51
    Reiter RJ, Acuña-Castroviejo D, Tan DX et al. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann NY Acad Sci 2001; 939: 200215.
  • 52
    Reiter RJ, Tan DX. What constitutes a physiological concentration of melatonin? J Pineal Res 2003; 34: 7980.
  • 53
    Kilic E, Hermann DM, Isenmann S et al. Effects of pinealectomy and melatonin on the retrograde degeneration of retinal ganglion cells in a novel model of intraorbital optic nerve transection in mice. J Pineal Res 2002; 32: 106111.
  • 54
    Parlakpinar H, Sahna E, Ozer MK et al. Physiological and pharmacological concentrations of melatonin protect against cisplatin-induced renal injury. J Pineal Res 2002; 33: 161166.
  • 55
    Jimenez JL, Nicolas JG, Alvarez S et al. Regulation of human immunodeficiency virus type 1 replication in human T lymphocytes by nitric oxide. J Virol 2001; 75: 46554663.